What are the legal implications to safeguard competition between partners of joint venture in the United States for a foreign fund?
I represent a Chinese fund considering what would be our first joint venture for investment a biotech company. Part of our U.S. investment strategy is to bring back the experience we gain in the United States to similar biotech investments and ventures in China. We are wary of the joint partner becoming competition in the future. How can we prevent that?